移动应用程序的开发和有效性,以改善心脏病患者的药物坚持
Raziyeh Ghafouri1, Roxana Karbaschi2, AliReza Mashhadi Hosein3
1Department of Medical Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ARYA atherosclerosis
|December 19, 2024
概括
一个新的移动应用程序有效地改善了心脏病患者的药物坚持. 这种干预措施在患者在出院后遵守治疗计划方面显示出显著的好处.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 医疗信息学 医疗信息学
背景情况:
- 心血管疾病 (CVD) 管理需要严格遵守治疗计划.
- 不良的药物坚持加剧了心血管疾病的进展,降低了生活质量.
- 开发创新工具对于支持患者在心脏护理中的自我管理至关重要.
研究的目的:
- 开发一个针对心脏病患者量身定制的移动应用程序.
- 评估本移动应用程序在提高药物服药的有效性.
- 评估应用程序对患者遵守治疗建议的影响.
主要方法:
- 该研究采用了两阶段的方法,包括通过级联模型开发移动应用程序.
- 121名住院的心脏病患者被招募并随机分为干预 (n=58) 和对照 (n=63) 组.
- 药物坚持被评估使用一个问卷在7日,14日和21日后释放,用SPSS20分析数据.
主要成果:
- 在干预组 (57.03±11.55岁) 和对照组 (56.75±11.38岁) 之间没有观察到显著的年龄差异.
- 与对照组相比,干预组在出院后的7日,14日和21日表现出明显更高的药物坚持 (P<0.01).
- 重复的测量分析表明,干预组内随着时间的推移,守率显著增加 (P<0.001).
结论:
- 开发的移动应用程序有效地改善了心脏病患者的药物坚持.
- 数字健康干预措施有望提高慢性疾病管理中的患者合规性.
- 这种移动工具可以支持心血管患者遵守他们处方的治疗方案.
相关概念视频
01:28Drug Therapy
38
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
38
01:30Pulse rhythm
759
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
759
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
01:23Holter Monitor: 24-Hour Monitoring
2
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
2
01:22Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
01:26Heart Failure Drugs: Inotropic Agents
516
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516